AnaptysBio
ANAB
136 hedge funds and large institutions have $601M invested in AnaptysBio in 2020 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 45 reducing their positions, and 19 closing their positions.
176% more call options, than puts
Call options by funds: $4.6M | Put options by funds: $1.67M
41% more capital invested
Capital invested by funds: $425M → $601M (+$175M)
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
3% more funds holding
Funds holding: 132 → 136 (+4)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4.48% less ownership
Funds ownership: 106.66% → 102.18% (-4.5%)
20% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$29M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.5M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.08M |
| 4 |
GA
Greenspring Associates
Owings Mills,
Maryland
|
+$4.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$34.4M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$18.1M |
| 3 |
SC
Sessa Capital
New York
|
-$8.76M |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$6.36M |
| 5 |
Millennium Management
New York
|
-$5.27M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
151
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$4K | -355 | Closed |
|
152
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | +$243 | +10 | New |
|
ANAB Hedge Fund Activity: Q4 2020 in Review
136 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q4 2020, worth a combined $601M — up 41% from $425M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ANAB positions and 19 closed out — a net gain of 4 holders — while 36 added to existing stakes and 45 trimmed.
The largest buyer was Perceptive Advisors, opening a new position worth an estimated $29M. The largest seller was Frazier Management, cutting an estimated $34.4M.
- 136 institutional investors held AnaptysBio (ANAB) as of Q4 2020, up from 132 in Q3 2020.
- Funds reported $601M of AnaptysBio stock for Q4 2020, up 41% quarter-over-quarter.
- 23 funds opened new AnaptysBio positions in Q4 2020 and 19 closed out, a net change of +4 holders.
- The largest AnaptysBio buyer in Q4 2020 was Perceptive Advisors, an estimated $29M added.
- The largest AnaptysBio seller in Q4 2020 was Frazier Management, an estimated $34.4M sold.
Based on aggregated 13F filings for Q4 2020.